Ovarian cancer cell lines were therefore used to investigate whether FANCF methylation is associated with cisplatin sensitivity, and these cisplatin-sensitive cells exhibited a densely methylated promoter region of the FANCF gene, which was accompanied by a lack of FANCF mRNA expression. The gene discussed is FANCF; the disease is ovarian carcinoma.